» Articles » PMID: 23224237

Reproductive Factors and Risk of Estrogen Receptor Positive, Triple-negative, and HER2-neu Overexpressing Breast Cancer Among Women 20-44 Years of Age

Overview
Specialty Oncology
Date 2012 Dec 11
PMID 23224237
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Aspects of reproductive history are among the most well-established breast cancer risk factors. However, relatively little is known about how they influence risk of different molecular subtypes of breast cancer, particularly among younger women. Using data from a population-based case-control study of women 20-44 years of age, we assessed the relationships between various reproductive factors and risk of estrogen receptor positive (ER+), triple-negative, and HER2-overexpressing breast cancers. Detailed reproductive histories were obtained through structured interviewer administered in-person questionnaires. Reproductive histories among control women (n = 941) were compared to those of ER+ cases (n = 781), triple-negative cases (n = 180), and HER2-overexpressing cases (n = 60) using polytomous logistic regression. Age at menarche, parity, and number of full-term pregnancies were similarly associated with risk of all three breast cancer subtypes. In contrast, age at first live birth, the interval between age at menarche and age at first birth, and breastfeeding were inversely associated with risk of triple-negative breast cancer (P values for trend 0.002, 0.006 and 0.018, respectively), but were not associated with risk of ER+ or HER2-overexpressing cancers. A strong inverse association between breastfeeding and risk of triple-negative breast cancer has now been consistently observed across numerous studies, and at present it is the most well-established protective factor for this aggressive and lethal form of breast cancer. Further studies clarifying the biological mechanisms underlying this relationship and confirming our results with respect to age at first birth and the interval between age at menarche and age at first birth are needed.

Citing Articles

Association between breastfeeding, mammographic density, and breast cancer risk: a review.

Ye D, Bai X, Xu S, Qu N, Zhao N, Zheng Y Int Breastfeed J. 2024; 19(1):65.

PMID: 39285438 PMC: 11406879. DOI: 10.1186/s13006-024-00672-7.


Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment.

Romero-Trejo D, Aguiniga-Sanchez I, Ledesma-Martinez E, Weiss-Steider B, Sierra-Mondragon E, Santiago-Osorio E Med Oncol. 2024; 41(8):200.

PMID: 38990440 PMC: 11239739. DOI: 10.1007/s12032-024-02403-8.


Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.

John E, Koo J, Phipps A, Longacre T, Kurian A, Ingles S Breast Cancer Res. 2024; 26(1):88.

PMID: 38822357 PMC: 11143591. DOI: 10.1186/s13058-024-01834-5.


The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis.

Kumar N, Ehsan S, Banerjee S, Fernandez Perez C, Lhuilier I, Neuner J J Natl Cancer Inst. 2024; 116(8):1210-1219.

PMID: 38445713 PMC: 11308168. DOI: 10.1093/jnci/djae056.


Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast.

Abubakar M, Klein A, Fan S, Lawrence S, Mutreja K, Henry J Breast Cancer Res. 2023; 25(1):97.

PMID: 37582731 PMC: 10426057. DOI: 10.1186/s13058-023-01692-7.


References
1.
Kim M, Ro J, Ahn S, Kim H, Kim S, Gong G . Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol. 2006; 37(9):1217-26. DOI: 10.1016/j.humpath.2006.04.015. View

2.
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100(14):8418-23. PMC: 166244. DOI: 10.1073/pnas.0932692100. View

3.
Millikan R, Newman B, Tse C, Moorman P, Conway K, Dressler L . Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2007; 109(1):123-39. PMC: 2443103. DOI: 10.1007/s10549-007-9632-6. View

4.
Li C, Beaber E, Tang M, Porter P, Daling J, Malone K . Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Cancer Res. 2012; 72(8):2028-35. PMC: 3328650. DOI: 10.1158/0008-5472.CAN-11-4064. View

5.
Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N . Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999; 91(11):943-9. DOI: 10.1093/jnci/91.11.943. View